Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) Files An 8-K

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that the independent Compensation Committee of the Board of Directors of Synergy approved the grant of an inducement stock option to purchase 50,000 shares of Synergy common stock to one new employee, with a grant date of September 19, 2016 (the “Q3 2016 Inducement Grant”).

Story continues below

The Q3 2016 Inducement Grant has an exercise price per share equal to the closing price of the Company’s common stock on September 19, 2016, the date of grant. The stock option has a 10 year term and vests in equal amounts on the anniversary of the date of grant over three years, subject to the new employee’s continued service with the Company through the respective vesting dates. The stock option was granted as an inducement equity award outside of the Company’s 20008 Equity Compensation Incentive Plan, as amended, and was made as an inducement material to such employee’s acceptance of employment with the Company.

An ad to help with our costs